
Henry Rodriguez
Clinical Director of the USF Diabetes Center, Morsani College of Medicine · University of South Florida Morsani College of Medicine
Credentials: · · ·
History
- Present
Morsani College of Medicine · University of South Florida Morsani College of Medicine
- Present
Center Clinical Director · University of South Florida Morsani College of Medicine
- Present
Pediatrics and Clinical Director · University of South Florida Morsani College of Medicine

- 1983–1987
Research
Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family
Nature · 1987 · 1,476 citations
Proteogenomics connects somatic mutations to signalling in breast cancer
Nature · 2016 · 1,323 citations
A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression
Science · 1987 · 1,203 citations

13 papers

12 papers
- CG
11 papers
- RG
11 papers

11 papers

10 papers

10 papers

10 papers
Grants
- 2014–2020
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $1.2M · University of South Florida
- 2009–2014
Type 1 Diabetes TrialNet at Indiana University Clinical Center
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $823.3K · Indiana University Indianapolis
- 2001–2008
Type 1 Diabetes TrialNet at Indiana University Clinical Center
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2.6M · Indiana University Indianapolis
- 2003–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $257K · Indiana University Indianapolis
Clinical trials
- 2016–2019
Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes
Principal investigator · Completed
Stanford University
- 2026–2028
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Site PI · Recruiting · Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2025–2027
Site PI · Recruiting · Phase 1, Phase 2
COUR Pharmaceutical Development Company, Inc.
- 2025–2027
Site PI · Recruiting · Phase 3
Eli Lilly and Company


